196 related articles for article (PubMed ID: 6205194)
21. Interplay between milrinone and adenosine in the inhibition of human platelet response.
Anfossi G; Massucco P; Piretto V; Mularoni E; Cavalot F; Mattiello L; Trovati M
Gen Pharmacol; 1996 Oct; 27(7):1149-54. PubMed ID: 8981060
[TBL] [Abstract][Full Text] [Related]
22. Adenosine potentiates lutropin-stimulated cyclic AMP production and inhibits lutropin-induced desensitization of adenylate cyclase in rat Leydig tumour cells.
Dix CJ; Habberfield AD; Cooke BA
Biochem J; 1985 Aug; 230(1):211-6. PubMed ID: 2996491
[TBL] [Abstract][Full Text] [Related]
23. The effects of siguazodan, a selective phosphodiesterase inhibitor, on human platelet function.
Murray KJ; England PJ; Hallam TJ; Maguire J; Moores K; Reeves ML; Simpson AW; Rink TJ
Br J Pharmacol; 1990 Mar; 99(3):612-6. PubMed ID: 2158847
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of phosphodiesterase inhibitors on platelet activating factor (PAF)- and adenosine diphosphate (ADP)-induced equine platelet aggregation.
Rickards KJ; Andrews MJ; Waterworth TH; Alexander GB; Cunningham FM
J Vet Pharmacol Ther; 2003 Aug; 26(4):277-82. PubMed ID: 12887610
[TBL] [Abstract][Full Text] [Related]
25. Effect of thromboxane synthetase inhibitors on platelet function: enhancement by inhibition of phosphodiesterase.
Smith JB
Thromb Res; 1982 Nov; 28(4):477-85. PubMed ID: 6891843
[TBL] [Abstract][Full Text] [Related]
26. Effect of hydrogen sulfide on cyclic AMP production in isolated bovine and porcine neural retinae.
Njie-Mbye YF; Bongmba OY; Onyema CC; Chitnis A; Kulkarni M; Opere CA; LeDay AM; Ohia SE
Neurochem Res; 2010 Mar; 35(3):487-94. PubMed ID: 19898983
[TBL] [Abstract][Full Text] [Related]
27. Effects of 7-ethoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1(2H)-phthalazinone (EG626) on the spinal trigeminal nucleus, ventral posteromedial nucleus, and sensory cortex.
Azuma H; Takashima Y; Ishikawa M; Sasa M; Fujiwara M
Jpn J Pharmacol; 1982 Oct; 32(5):767-74. PubMed ID: 6294392
[TBL] [Abstract][Full Text] [Related]
28. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
Williams KA; Murphy W; Haslam RJ
Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
[TBL] [Abstract][Full Text] [Related]
29. Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclase.
Mills DC; Figures WR; Scearce LM; Stewart GJ; Colman RF; Colman RW
J Biol Chem; 1985 Jul; 260(13):8078-83. PubMed ID: 2989276
[TBL] [Abstract][Full Text] [Related]
30. N6-(Phenylisopropyl)adenosine prevents glucagon both blocking insulin's activation of the plasma-membrane cyclic AMP phosphodiesterase and uncoupling hormonal stimulation of adenylate cyclase activity in hepatocytes.
Wallace AV; Heyworth CM; Houslay MD
Biochem J; 1984 Aug; 222(1):177-82. PubMed ID: 6089755
[TBL] [Abstract][Full Text] [Related]
31. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
Shafiee-Nick R; Pyne NJ; Furman BL
Br J Pharmacol; 1995 Aug; 115(8):1486-92. PubMed ID: 8564209
[TBL] [Abstract][Full Text] [Related]
32. The phorbol ester TPA inhibits cyclic AMP phosphodiesterase activity in intact hepatocytes.
Irvine F; Pyne NJ; Houslay MD
FEBS Lett; 1986 Nov; 208(2):455-9. PubMed ID: 2430836
[TBL] [Abstract][Full Text] [Related]
33. Resensitization of hepatocyte glucagon-stimulated adenylate cyclase can be inhibited when cyclic AMP phosphodiesterase inhibitors are used to elevate intracellular cyclic AMP concentrations to supraphysiological values.
Murphy GJ; Houslay MD
Biochem J; 1988 Jan; 249(2):543-7. PubMed ID: 2449179
[TBL] [Abstract][Full Text] [Related]
34. Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Schmitz W; Scholz H; Starbatty J; Stein B; Wenzlaff H
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):90-100. PubMed ID: 1723153
[TBL] [Abstract][Full Text] [Related]
35. Potentiation of P1075-induced K+ channel opening by stimulation of adenylate cyclase in rat isolated aorta.
Linde C; Quast U
Br J Pharmacol; 1995 Jun; 115(3):515-21. PubMed ID: 7582466
[TBL] [Abstract][Full Text] [Related]
36. Treatment of intact hepatocytes with the calcium ionophore A23187 perturbs both the synthesis and the degradation of the second messenger cyclic AMP. Actions on adenylate cyclase and cyclic AMP phosphodiesterase activities.
Irvine FJ; Houslay MD
Biochem Pharmacol; 1988 Jul; 37(14):2773-9. PubMed ID: 2456067
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effects of S-(1,2-dicarboxyethyl)glutathione on collagen-induced platelet aggregation; enhancements of cyclic AMP level and adenylate cyclase activity in platelets by S-(1,2-dicarboxyethyl)glutathione.
Tsuboi S; Fujiwara E; Ogata K; Sakaue A; Nakayama T; Ohmori S
Biol Pharm Bull; 1993 Nov; 16(11):1083-6. PubMed ID: 8312859
[TBL] [Abstract][Full Text] [Related]
38. Potentiation of anti-aggregating activity of PGI2 by 7-ethoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1(2H)-phthalazinone (EG-626) in rabbit platelets in vitro.
Tanaka K; Harada Y; Iwata M; Katori M
Prostaglandins; 1980 Aug; 20(2):255-68. PubMed ID: 6997930
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of lymphocyte-mediated cytolysis and cyclic AMP phosphodiesterase by erythro-9-(2-hydroxy-3-nonyl)adenine.
Duncan GS; Wolberg G; Schmitges CJ; Deeprose RD; Zimmerman TP
J Immunopharmacol; 1982; 4(1-2):79-100. PubMed ID: 6296234
[TBL] [Abstract][Full Text] [Related]
40. Cyclic nucleotides and platelet aggregation. Effect of aggregating agents on the activity of cyclic nucleotide-metabolizing enzymes.
Barber AJ
Biochim Biophys Acta; 1976 Sep; 444(2):579-95. PubMed ID: 9149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
